2013 Annual Meeting Posters: Monday, May 21, 2012

<< Sunday | Posters Home | Tuesday>>

	indicates a poster featured in a Poster Tour: (ticketed session with complimentary but limited registration)
		Sunday, May 19, 2013, 11:00 - 11:45 AM: Esophageal and Stomach Monday, May 20, 2013, 11:00 - 11:45 AM: HPB Tuesday, May 21, 2013, 11:00 - 11:45 AM: Small Bowel and Colon-Rectal
	indicates a Poster of Distinction.

Monday, May 20, 2013
Basic: Colon-Rectal
Mo1834	Plasma Levels of the Proangiogenic Proteins Angiogenin and Interleukin-8 Are Significantly Increased in Patients with Colorectal Cancer M. C. Shantha Kumara H, Surgery, St Luke Roosevelt Hospital, New york, NY
Mo1835	Intestinal Permeability Is Increased During Postoperative Ileus in Mice Martin E. Kreis, Surgery (CBF), Charité University Medicine, Berlin Germany
Basic: Esophageal
Mo1836	Bile Acid at Low pH Can Cause Dilatation of Inter-Cellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating WNT and BMP Signaling Sayak Ghatak, Biology, University of Rochester, Rochester, NY
Basic: Hepatic
Mo1837	Beneficial Effects of Diazoxide on Hepatic Ischemia/Reperfusion Injury Ana Maria M. Coelho, Gastroenterology, University of Sao Paulo, Sao Paulo Brazil
Basic: Pancreas
Mo1838	PTK6 Regulates Migration and Invasion of Pancreatic Cancer Cells with ERK1/2 Dependent Pathway Hiroaki Ono, Surgery, Michigan State University, East Lansing, MI
Mo1839	Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer: What’s One Got to Do with the Other? A New Role for OPN Konrad Sarosiek, Surgery, Thomas Jefferson University, Philadelphia, PA
Mo1840	Local and Systemic Effects of Aging on Acute Pancreatitis Ana Maria M. Coelho, Gastroenterology, University of Sao Paulo, Sao Paulo Brazil
Clinical: Biliary
Mo1687	Introperative Cholangiogram Reduces Risk of Bile Duct Injury During Cholecystectomy: Results from a National Quality Registry Björn Törnqvist, Department of Clinical Science, Intervention and Technology , Karolinska Institutet, Stockholm Sweden
Mo1689	Post-Cholecystectomy Acute Bile Duct Injuries Vinay Kumar Kapoor, Surgical Gastroenterology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, UP India
Mo1690	Hepatolithiasis: Transhepatic Team Management Janak A. Parikh, Surgery, IN Univ School of Medicine, Indianapolis, IN
Mo1691	En Bloc Resection of Hepatoduodenal Ligament for Advanced Biliary Malignancy Yuji Kaneoka, Surgery, Ogaki Municipal Hospital, Ogaki Japan
Mo1692	Extended Hepatectomy with Portal and Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma Minoru Esaki, Hepato-biliary pancreatic surgery, National Cancer Center Hospital , Tokyo Japan
Mo1693	Percutaneous Transhepatic Gallbladder Drainage Without Cholecystectomy Is Optimum Procedure in High-Risk Patients Masanori Akada, surgery, Surgery, South miyagi medical center, Tohoku University, Sendai Japan
Mo1694	Major Bile Duct Injury Requiring Operative Reconstruction After Laparoscopic Cholecystectomy: A National Perspective, 2001-2009 Taranjeet Kaur, General Surgery, Oregon Health & Science University, Portland, OR
Mo1695	Percutaneous Cholecystostomy Placement in a High Risk Population with Acute Cholecystitis Joseph Alfred Blansfield, Jr., Surgical Oncology, Geisinger Medical Center, Danville, PA
Clinical: Colon-Rectal
Mo1696	Congenital Pouch Colon: A Clinical Study Kewal Krishan Maudar, G.I. Surgery , Paediatric Surgery, Bhopal Memorial Hospital & Research Centre, Gandhi Medical College, Bhopal, Madhya Pradesh India
Mo1697	Colonic Disasters Approached by Emergent Total Colectomy: Lessons Learned from 120 Consecutive Cases Michael Schweigert, Department of General and Thoracic Surgery, Klinikum Nuremberg Nord, Nuremberg Germany
Mo1698	A Comparison of Tumour and Host Determinants of Outcome in Screen Detected Versus Non-Screen Detected Colorectal Cancer: A Contemporaneous Study David Mansouri, Academic Department of Surgery, University of Glasgow, Glasgow United Kingdom
Mo1699	Infective Complications Following Colorectal Cancer Resection: Enhanced Recovery Confers No Advantage over Conventional Care Michelle Leana Ramanathan, Department of Surgery, University of Glasgow, Glasgow United Kingdom
Mo1700	Palliative Surgery for Malignant Bowel Obstruction: A Systematic Review Terrah J. Paul Olson, General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Mo1701	Surgical Stricturoplasty in the Treatment of Pouch Strictures Xian-rui Wu, Departments of Colorectal Surgery, Cleveland Clinic, Cleveland , OH
Mo1702	Outpatient Anal Exploration and Fistula Treatment in Patients with Symptomatic Peri-Anal Crohn’s Disease: Preliminary Report Edoardo Iaculli, Tor Vergata, Rome Italy
Mo1703	Clinical Profile and Skeletal Muscle Histopathology of Patients Affected with Early Diagnosed Colorectal Cancer: Diagnostic and Prognostic Markers of Disease? Mario Gruppo, Department of Surgical, Oncological and Gastroenterological Sciences, University Hospital of Padua, Padova Italy
Mo1704	Risk Factors for Failure of Percutaneous Drainage and Need for Re-Operation Following Symptomatic Gastrointestinal Anastomotic Leak Seth Felder, Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
Mo1706	The Impact of Laparoscopic Versus Open Approach on Re-Operation Rate After Segmental Colectomy Paul Speicher, Surgery, Duke University Medical Center, Durham, NC
Mo1707	Insurance Affects Readmission After GI Surgery: A Longitudinal Analysis Zeling Chau, Department of General Surgery, Division of Surgical Oncology, University of Massachusetts, Beth Israel Medical Center- Harvard Medical School, Worcester, MA
Mo1708	Local Excision of T1 and T2 Rectal Cancer: Proceed with Caution Mohamed M. Elmessiry, Colorectal Surgery, Cleveland Clinic Florida, Weston, FL
Mo1709	Outcomes of Survival in Converted Laparoscopic Resections for Colorectal Malignancy over a 10-Year Period Arthur Yushuva, Colorectal Surgery, Abington Memorial Hospital, Abington, PA
Mo1710	Alvimopan Use Is Associated with Reduced Length of Stay and Direct Hospital Costs in Laparoscopic Bowel Resections Aaron G. LEwis, Huntington Memorial Hospital, Pasadena, CA
Mo1711	Lymph-Nodes Harvest Might Be Ameliorated by Ex-Vivo Intra-Arterial Methylene Blue Dye Injection After Colorectal Cancer Surgery Pierpaolo Sileri, Surgery, University of Rome Tor Vergata, Rome Italy
Mo1712	The Effects of Advanced Age on Post-Operative Morbidity and Mortality Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Sarah Jane McPartland, Surgery, Tufts Medical Center, Shrewsbury, MA
Clinical: Esophageal
Mo1714	Gastroesophageal Junction Tumors Clinically Staged cT2: Accuracy of Staging Results and Therapeutic Consequences at Two Academic Centers Daniel Vallbohmer, Department of Surgery, University of Dusseldorf, Dusseldorf Germany
Mo1715	Outcomes of Esophagectomy for Esophageal Achalasia in the United States Daniela Molena, Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
Mo1716	Comparison of Long Term Survival After Endoscopic Resection Vs. Ablation in Early Esophageal Cancer: An Analysis of Surveillance Epidemiology and End Results Data Attila Dubecz, Surgery, Klinikum Nurnberg, Nurnberg Germany
Mo1717	Diagnosis and Surgical Treatment of Esophageal Carcinoma with Coexistent Intrathoracic Great Vessel Anomalies Long-Qi Chen, Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan China
Mo1718	Esophagectomy for Cancer Can Be Performed Safely and with Good Perioperative Outcomes in Octagenerians Vadim P. Koshenkov, Surgery, University of Miami, Miami, FL
Mo1719	The Clinical Spectrum of Esophagogastric Junction Outflow Obstruction Identified via High Resolution Manometry Poochong Timratana, Department of Surgery, University of Rochester Medical Center, Rochester, NY
Mo1720	Economic Impact of an Enhanced Recovery Pathway for Esophagectomy Lawrence Lee, Surgery, McGill University Health Centre, Montreal, QC Canada
Mo1721	Can an Effective Nissen Fundoplication Improve the Weak Motility of Barrett’s Esophagus? Sergio Szachnowicz, Department of Gastroenterology, Esophageal Surgical Division - University of Sao Paulo Medical School - Brazil, São Paulo Brazil
Mo1722	Laparoscopic Nissen - Hill Hybrid: A Promising Solution for Type III Para-Esophageal Hernia Ralph W. Aye, Division of Thoracic Surgery, Swedish Medical Center and Cancer Institute, Seattle, WA
Mo1723	Does Delayed Surgery Have an Impact on Outcome After Neoadjuvant Chemoradiotherapy (NACRT) in Patients with Carcinoma Esophagus? Rajesh Gupta, Surgical Gastroenterology Division, Postgraduate Institute of Medical Education and Research, Chandigarh India
Mo1724	Prospective Study of Quality of Life After Laparoscopic Paraesophageal Hernia Repair with Bio-Prosthetic Mesh Kashif A. Zuberi, Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
Mo1725	Long Term Outcomes of Re-Do Fundoplication in Elderly (> 65 Years) Patients: A Single Center Experience Parth Kishore Shah, Creighton University, Omaha, NE
Mo1726	Laparoscopic Versus Open Esophagectomy: A Clinical and Cost Analysis Ernest L. Rosato, Department of General Surgery, Thomas Jefferson University, Philadelphia, PA
Mo1727	Comparing the Post-Operative Manometric Characteristics of the Laparoscopic Nissen Fundoplication and the Laparoscopic Hill Repair Richard C. Wiseman, Division of Thoracic Surgery, Swedish Medical Center and Cancer Institute, Seattle, WA
Mo1728	A Combined Nissen Fundoplication with Hill Gastroplasty Is an Alternative to Collis-Nissen Repair in the Treatment of Short Esophagus Zeljka Jutric, Division of Thoracic Surgery , Swedish Medical Center and Cancer Institute , Seattle , WA
Mo1729	Safety and Symptom Control Efficacy of ePTFE-mesh in Hiatal Hernia Repair with Nissen Fundoplication for Gastroesophageal Reflux Johannes Miholic, Medical University of Vienna, Vienna Austria
Mo1731	Incomplete Lower Esophageal Sphincter Relaxation on High-Resolution Manometry Is an Independent Predictor of Solid Diet Failure in Post-Roux-en-Y Gastric Bypass Patients Ana C. Tuyama, Gastroenterology, Brigham and Women's Hospital, Boston, MA
Clinical: Hepatic
Mo1732	Transplantation for HCC Improves Progression Free Survival But Not Overall Survival When Compared to Resection Rafael Pieretti- Vanmarcke, Department of Surgery, , Massachusetts General Hospital, Harvard Medical School, Boston, MA
Mo1733	Influence of Preoperative Laboratory Values on Perioperative Mortality Following Hepatic Resection for Malignancy Mashaal Dhir, University of Nebraska Medical Center, Omaha, NE
Mo1734	Resected Splenic Masses Discovered on Imaging Are Frequently Malignant: A Review of 148 Cases Ciaran Thomas Bradley, Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
Mo1735	Analysis of Clinicopathological Factors Contributing an Actual 5 Year Survival After Hepatectomy for Intrahepatic Cholangiocarcinoma Shutaro Hori, Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo Japan
Mo1736	Hepatic Metastasectomy Offers Improves Local Tumor Control Among Patients with Recurrent Colorectal Metastases Victor M. Zaydfudim, Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN
Clinical: Pancreas
Mo1737	The Effect of Splenectomy on Complication Rates After Distal Pancreatectomy: A Meta-Analysis Noah Rozich, Department of Surgery, University of Wisconsin , Madison, WI
Mo1738	Risk-Benefit Assessment of the Use of Intraperitoneal Drainage After Pancreaticoduodenectomy Pablo E. Serrano, Surgery, Princes Margaret Cancer Centre, Toronto General Hospital, University of Toronto, Toronto, ON Canada
Mo1739	Efficacy of Wrapping the Pancreatic Stump with a Bioabsorbable Sheet and Fibrin Glue After Distal Pancreatectomy Daisuke Ban, Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo Japan
Mo1740	Predictors of Same Hospital Readmission Versus Readmission to Another Hospital After Surgery for Pancreatic Cancer: A SEER-Medicare Study Marquita Renee Decker, Department of Surgery, Health Innovation Program, University of Wisconsin, University of Wisconsin, Madison, WI
Mo1741	Bridging the Gap in Hospital Accounting: Acute Pancreatitis 2001-2009 Kenneth W. Bueltmann, Jr, Surgery, Advocate Illinois Masonic Medical Center, Chicago, IL
Mo1742	Clinico-Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas Pablo E. Serrano, Surgery, Princes Margaret Cancer Centre, Toronto General Hospital, University of Toronto, Toronto, ON Canada
Mo1743	Risk Factors and Management of Postpancreatectomy Hemorrhage in over 1000 Pancreatic Resections Ulrich Wellner, Department of Surgery, Clinic for General and Visceral Surgery, University Hospital of Schleswig-Holstein Campus Lübeck, University of Freiburg Medical Center, Freiburg Germany
Mo1744	Mortality of Severe Acute Pancreatitis (SAP) Patients with Infected Necrosis or Persistent Organ Failure Is High But May Be Reduced by Specialist Care and Innovative Therapeutic Modalities Rami Radwan, Dempartment of Surgery, Royal Gwent Hospital, Barry United Kingdom
Mo1745	Peri-Operative Epidural May Not Be the Preferred Form of Analgesia in Select Patients Undergoing Pancreaticoduodenectomy Trevor Axelrod, Loyola University Chicago Stritch School of Medicine, Forest Park, IL
Mo1746	Postoperative Serum Amylase Predicts Pancreatic Fistula Following Pancreaticoduodenectomy Jordan M. Cloyd, Surgery, Stanford University, Stanford, CA
Mo1747	Significance of Radiographic Splenic Vessel Involvement in Pancreatic Ductal Adenocarcinoma (PDAC) of the Body and Tail Nathaniel B. Paull, Surgery, Virginia Mason Medical Center, Seattle, WA
Mo1748	Outcomes of Surgery for Chronic Pancreatitis Rajesh Gupta, Surgical Gastroenterology Division, Postgraduate Institute of Medical Education and Research, Chandigarh India
Mo1749	Patients with Familial Pancreatitis Have a Better Quality of Life After Total Pancreatectomy with Islet Autotransplantation Katherine Ann Morgan, Surgery, MUSC, Charleston, SC
Mo1750	Irreversible Electroporation of Unresectable Soft Tissue Tumors with Vascular Invasion Prejesh Philips, Surgical Oncology, University of Louisville, Louisville, KY
Mo1751	Clinical Significance of Portomesenteric Vein Abutment Among Patients with Pancreatic Ductal Adenocarcinoma Victor M. Zaydfudim, Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN
Mo1752	Does Weight Affect Outcomes Following Total Pancreatectomy with Islet Autotransplantation? Katherine Ann Morgan, Surgery, MUSC, Charleston, SC
Mo1753	Improving the Detection of Mitoses in Pancreatic Neuroendocrine Tumors Using Phosphohistone H3 Stephanie L. Goff, Surgical Oncology, Massachusetts General Hospital, Boston, MA
Mo1754	The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary Versus Intestinal Subtypes of Ampullary Cancers Sanjay S. Reddy, Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
Mo1755	Does Time Interval Between Chemoradiation and Surgery Affect Outcomes in Pancreatic Cancer? Kathryn Tzung-kai Chen, Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
Clinical: Small Bowel
Mo1756	Gastrointestinal Stromal Tumors of Extraintestinal Origin: Prognosis Based on Location Joyce Wong, Surgery, Moffitt Cancer Center, Tampa, FL
Mo1757	Diagnostic Strategy for Acute Abdomen Caused by Perforation of the Gastrointestinal Tract: Can Computed Tomography Detect Perforated Site Even in the Small and Large Bowel? Tatsuya Ueno, Surgery, Southmiyagi Medical Center, Shibata-gun Japan
Mo1758	Ileo-Cecal Resection in Crohn's Disease Patients: Clinical Impact on Quality of Life and Nutrition. Edoardo Iaculli, Tor Vergata, Rome Italy
Mo1759	Role of Gastrografin Challenge in Early Postoperative Small Bowel Obstruction Mohammad A. Khasawneh, Trauma, Critical Care and General Surgery, Mayo Clinic, Rochester, MN
Mo1760	Assessment of Postoperative Complications in Patients with IBD: A Single Academic Medical Center Experience Samantha Jane Quade, General Surgery, University of Washington, Seattle, WA
Mo1761	Laparoscopic Vs. Open Unilateral Inguinal Hernia Repairs: A NSQIP Analysis Muhammad Asad Khan, Staten Island University Hospital, Staten Island, NY
Mo1762	Long-Term Outcomes Following Endoscopic Vs. Transduodenal Ampullectomies for Ampullary Adenomas Abhishek Mathur, Morsani College of Medicine, Tampa, FL
Clinical: Stomach
Mo1763	Hemi-Double Stapling Technique Versus Hand-Suture for Billroth-I Gastroduodenostomy: An Analysis of 84 Consecutive Patients Akira Ouchi, Department of Surgery, Chita City Hospital, Aichi Japan
Mo1764	Preoperative Chemotherapy Results in Unpredictable Response in Gastric Cancer: No Magic Bullet Houssam Osman, Surgery, Methodist Dallas Medical Center, Dallas, TX
Mo1765	The Development of Ulcer Disease After Roux-en-Y Gastric Bypass Usha Karuna Coblijn, Sint Lucas Andreas Ziekenhuis, Haarlem Netherlands
Mo1766	Current Treatment Strategy for Early Gastric Cancer at a New York Urban Medical Center Shinichi Fukuhara, Department of Surgery, Beth Israel Medical Center, New York, NY
Mo1767	Development and Validation of PGSAS-45, an Integrated Questionnaire to Assess Postgastrectomy Syndrome Koji Nakada, Surgery, , The Jikei University School of Medicine, Japan Postgastrectomy Syndrome Working Party, Tokyo Japan
Mo1770	Depression, Anxiety, and Stress Reduction After Bariatric Surgery John M. Morton, Surgery, Stanford University, Stanford, CA
Translational Science: Colon-Rectal
Mo2130	Minimally Invasive Full Thickness Colonic Resection: A Novel Localised Excision Procedure Adela Brigic, Department of Surgery, St. Mark's Hospital and Academic Institute, London, London United Kingdom
Mo2131	Risk Factors for Postoperative Ileus in Patients Undergoing Laparoscopic Colorectal Surgery Udo Kronberg, Colorectal Unit, Clinica Las Condes, Santiago Chile
Translational Science: Other
Mo2132	Accurate Haemodynamic and Image Based Assessment of Blunt Traumatic Splenic Injury May Identify Those Who Will Benefit from a Conservative Approach Chris Brown, General/Upper GI Surgery, Gwent Institute for Minimal Access Surgery, Newport United Kingdom
Mo2133	Management of Splenic Cysts: Does Size Really Matter? Christopher Kenney, Surgery, NorthShore University HealthSystem, Chicago, IL